Specialities

Specialities

Alzheimer's Disease and Dementia
Brain Trauma
COVID-19
Epilepsy
Headache Disorders
Neurodegenerative Diseases
Movement Disorders
Multiple Sclerosis
Neuroimmunology
Neurological Oncology
Neurometabolic Disease
Neuromuscular Diseases
Neuropathic Pain
Stroke
Neurosurgery
Pediatric Neurology
Parkinson's Disease
Psychiatric Disorders
Rare Diseases
Sleep Disorders
Central Nervous Disorders
Neuroradiology
Search

Trending Topic

Conceptual design with brain and red abstract background. Horizontal banner.
15 mins

Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Mechanical thrombectomy: Evidence basis and future directions

Abdelmageet Hassan, Sumanjit Gill

Both intracerebral hemorrhage and ischemic stroke continue to be the leading causes of disability and the second leading causes of death worldwide.1,2 The burden is largest in low- and middle-income countries, which have seen rapid recent population growth. Large vessel occlusion (LVO – internal carotids, vertebrals and the proximal branches of the circle of Willis) accounts for 20% of all acute ischemic strokes (AISs) […]

touchREVIEWS in Neurology. 2026;22(1):Online ahead of journal publication

Connect With Us:

Facebook
X (Twitter)
Instagram
Youtube
Linkedin

Free CME Accredited Learning

Our accredited content is designed to impact patient health outcomes, by ensuring that it provides you with a learning experience that will positively impact your clinical practice, based on adult learning preferences and intuitive instructional design. All activities are developed in collaboration with leading faculty and education partners.

touchNEUROLOGY

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
39 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchTALKS

Targeting pathogenic mechanisms in gMG: From complement- and FcRn-directed therapies to B- and T-cell-targeted approaches

Dr. Richard Nowak

An expert highlights unmet needs in gMG and the potential of targeted therapies to improve patient outcomes.

Translations available:
36 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCASES

The art of diagnosing CIDP: Strengthening diagnostic confidence

Prof. Dr. Claudia Sommer, Dr. Filip Eftimov

Two European neurology experts review three cases, focusing on identifying variants of chronic inflammatory demyelinating polyradiculoneuropathy and applying diagnostic criteria

Translations available:
36 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCASES

Cracking the code of CIDP: Mastering diagnostic precision

Dr Karissa Gable, Dr Jeffrey Allen

Two US neurology experts review three cases, focusing on identifying variants of chronic inflammatory demyelinating polyneuropathy and applying diagnostic criteria

Translations available:
32 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCASES

Diagnosis, multidisciplinary monitoring and individualized management in late-onset Pompe disease

Prof. John Vissing, Prof. Pascal Laforêt

Case-based expert insights on diagnosis, monitoring and individualized management in LOPD.

Translations available:
55 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION

Diagnosis and treatment of patients with Lennox-Gastaut syndrome

Prof. Nicola Specchio, Dr Raidah Al-Baradie, Dr Taoufik Alsaadi, Prof. Eiji Nakagawa, Prof. Hideo Yamanouchi

Expert faculty discuss the management of patients with Lennox–Gastaut syndrome in Japan and the Gulf

Translations available:
39 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT FOCUS

Bridging the diagnostic and therapeutic gaps in Fabry disease management

Dr Raphael Schiffmann, Ms Dawn Laney, Dr Ozlem Goker-Alpan

Fabry disease experts discuss timely diagnosis and individualized care using genetic and clinical insights.

Translations available:
18 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT FOCUS

Focus on treatment advances for ATTRv: A heterogeneous, highly debilitating and ultimately fatal disease

Dr Chafic Karam

This activity explores red-flag symptoms, diagnostic urgency and treatment advances in ATTRv amyloidosis.

39 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION

Accelerating myasthenia gravis diagnosis and treatment: Practical strategies and therapeutic advances

Dr Carolina Barnett-Tapia, Prof. Nils Erik Gilhus

Watch experts discuss strategies to accelerate MG diagnosis and treatment, plus consider emerging therapies.

Translations available:
12 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT FOCUS

The potential of BTKi therapies in delaying MS progression

Prof. Xavier Montalban

Join an expert as they discuss MS pathophysiology and the potential of BTK inhibitors to delay progression.

29 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION

Reducing burden of disease in gMG: Exploring the role of FcRn inhibitors

Prof. Michael Nicolle, Dr Karissa Gable, Ms Missy Pittman

Watch three experts discuss the role of FcRn inhibitors in the management of generalized myasthenia gravis

33 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION

Integrating treatment advances for alpha-mannosidosis into effective MDT care

Dr Barbara Burton, Dr Christina Lampe, Dr Can Ficicioglu

Experts discuss optimization of multidisciplinary care of alpha-mannosidosis along the patient’s lifespan.

Translations available:
64 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCONGRESS

Expanding horizons for patients with Pompe disease: Using data to guide clinical practice

Prof. Tahseen Mozaffar, Dr Jennifer L Cohen, Prof. Benedikt Schoser

Leading experts in Pompe disease explore key data from WMS 2024 and WORLDSymposium 2025.

Translations available:
35 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT FOCUS

Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life

Dr AeRang Kim, Dr Rebecca Brown, Dr Kaleb Yohay

Three experts share insights into the treatment and care of patients with NF1 from childhood to adulthood.

33 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION

Pharmacological management of agitation in Alzheimer's dementia: Rationale and evidence for new and emerging treatment options

Prof. Jeffrey Cummings, Prof. Krista Lanctôt, Prof. James Galvin

Three experts consider agitation in Alzheimer’s dementia with a focus on pharmacological treatment options.

Translations available:
47 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchTALKS

Intracranial haemorrhage related to direct oral anticoagulant medications: Latest evidence for reversal strategies

Prof. Dr. med. Jan Beyer-Westendorf

Watch an expert in thrombosis and haemostasis address reversal strategies in patients with direct oral anticoagulant-associated intracranial haemorrhage (DOAC-ICH).

Translations available:
34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS

The path from detection to personalized long-term care for Fabry disease

Prof. Aleš Linhart, Dr Eric Wallace, Prof. William Wilcox

Fabry disease experts discuss early diagnosis, organ monitoring, long-term individualized care and future directions.

Translations available:
Series of 3
CE/CME accredited
touchCurriculum

Agitation in Alzheimer’s dementia

Learn more about the prevalence, impact and management of agitation in Alzheimer’s dementia.
39 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION

Early diagnosis and treatment of NMOSD: Practical insights

Prof. John Chen, Prof. Friedemann Paul

A neurologist and a neuro-ophthalmologist discuss best practices for early diagnosis and treatment of NMOSD

Translations available:
Load More...

Society & Congress Partners

touchNEUROLOGY is proud to partner with leading medical societies and congresses from around the world to bring you news and insight from virtual and live events

View All

All touchIME CME activities are accredited. Learners can claim ACCME, ANCC, ACPE or EBAC credits upon completion of the activities. This content is for healthcare professionals only.

Latest Medical Education - straight to your inbox

Close Popup